Logo.jpg
Nebula Genomics Strengthens Advisory Board with Appointment of Russ Altman, M.D., Ph.D.
17 oct. 2022 08h00 HE | ProPhase Labs, Inc.
GARDEN CITY, NY, Oct. 17, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth-oriented and diversified diagnostics, genomics and biotech company, today announced that its wholly...
Logo.jpg
ProPhase Labs to Present at the H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022 (HYBRID CONFERENCE)
06 sept. 2022 08h15 HE | ProPhase Labs, Inc.
GARDEN CITY, NY, Sept. 06, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, today announced it will be...
Logo.jpg
ProPhase Labs Announces Record Second Quarter 2022 Financial Results
11 août 2022 08h00 HE | ProPhase Labs, Inc.
Record Q2 2022 Net Revenues of $29.1 Million; Up 218% Year-over-Year Record Q2 2022 Net Income of $7.4 Million; Up 633% Year-over-Year Management to Host Conference Call Today at 11:00...
Logo.jpg
ProPhase Labs to Host Second Quarter 2022 Financial Results Conference Call on Thursday, August 11, 2022 at 11:00 a.m. Eastern Time
04 août 2022 20h33 HE | ProPhase Labs, Inc.
GARDEN CITY, NY, Aug. 04, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, will hold a conference call on...
Logo.jpg
ProPhase Labs Announces New $6 Million Stock Repurchase Plan
26 juil. 2022 08h00 HE | ProPhase Labs, Inc.
Company also provides additional information on ProPhase BioPharma Garden City, NY, July 26, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a rapidly growing and...
Logo.jpg
ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
21 juil. 2022 18h00 HE | ProPhase Labs, Inc.
Garden City, NY, July 21, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, today announced that it has granted an inducement stock option...
Logo.jpg
ProPhase Labs Announces Licensing of New Investigational Cancer Compounds
21 juil. 2022 08h30 HE | ProPhase Labs, Inc.
Confirms Quarterly Growth continues year-over-year Announces significant progress being made in Genomics Business Company to Host Live Webcast to Discuss Business Developments Today at 11:30...
Logo.jpg
ProPhase Labs to Host Live Webcast to Discuss Business Developments on Thursday, July 21, 2022
19 juil. 2022 08h30 HE | ProPhase Labs, Inc.
Garden City, NY, July 19, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, today announced that it will host a live webcast on Thursday,...
Logo.jpg
ProPhase Labs Announces Formation of ProPhase BioPharma, Inc. (PBIO) for the Licensing and Development of Novel Drugs, Compounds and Biotechnology
28 juin 2022 08h30 HE | ProPhase Labs, Inc.
Company Also Announces First Licensing Agreement for PBIO with Global BioLife, Inc. for broad based Anti-Viral Fighting Compounds Equivir and Equivir G Garden City, NY, June 28, 2022 (GLOBE...
Logo.jpg
ProPhase Labs Announces Significant Laboratory Expansion
13 juin 2022 08h30 HE | ProPhase Labs, Inc.
Expanding in-house clinical testing capabilities Initiates plans to build new genomics laboratory Garden City, NY, June 13, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a...